The trajectory of Viagra, initially marketed by copyright, presents a intricate case study for stakeholders considering the drug landscape . Although its groundbreaking success and generation of vast in earnings , the patent lapse has opened the floodgates for competing medications, significantly eroding earnings opportunities. This change raises q